Pantoprazol Ametas (Pantoprazole)

Pantoprazole, the active ingredient in Pantoprazol Ametas, is a proton pump inhibitor presented as a 40 mg tablet for oral use. It reduces stomach acid production and is used to treat gastro‑oesophageal reflux disease and related conditions in adults.

GNH USA supplies Pantoprazol Ametas as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Pantoprazol Ametas is a proton pump inhibitor that acts on the gastric acid secretion pathway. It is indicated for several acid‑related disorders: - Gastro‑oesophageal reflux disease (GERD): provides symptomatic relief and promotes healing of the oesophageal lining. - Erosive oesophagitis: accelerates ulcer healing in the oesophagus. - Zollinger‑Ellison syndrome: controls excessive gastric acid production associated with gastrin‑secreting tumours. - Peptic ulcer disease (duodenal and gastric): supports ulcer healing and reduces recurrence risk. - Helicobacter pylori eradication regimens: used as part of combination therapy to improve eradication rates.

Pantoprazol Ametas may cause a range of adverse reactions. Most are mild and reversible.

Common Side Effects: - Headache: mild to moderate intensity. - Diarrhoea: loose stools without blood. - Nausea: feeling of queasiness. - Abdominal pain: mild cramping. - Flatulence: increased intestinal gas. - Constipation: infrequent, hard stools.

Serious or Rare Side Effects: - Severe allergic reaction (anaphylaxis): rash, swelling, difficulty breathing. - Clostridioides difficile infection: persistent watery diarrhoea. - Low magnesium levels (hypomagnesemia): muscle cramps, irregular heartbeat. - Bone fractures: increased risk with long‑term use. - Liver enzyme elevation: abnormal liver function tests. - Acute interstitial nephritis: kidney inflammation presenting with fever and rash.

Pantoprazol Ametas should be used with caution in specific clinical situations.

- Assess renal function: adjust use in severe renal impairment. - Monitor for infections: prolonged acid suppression may increase risk of gastrointestinal infections. - Evaluate bone health: long‑term therapy may affect calcium absorption. - Review concomitant medications: potential for altered absorption of drugs requiring acidic pH. - Pregnancy and lactation: weigh benefits against potential risks; use only if clearly indicated. - Store at below 25°C: keep in the original packaging, protect from moisture and light.

Pantoprazol Ametas can affect the pharmacokinetics of several co‑administered medicines.

Major Interactions (Avoid): - Antifungal azoles (ketoconazole, itraconazole): reduced absorption due to increased gastric ppH. - HIV protease inhibitors (ritonavir, atazanavir): decreased plasma concentrations. - Clopidogrel: diminished antiplatelet effect.

Moderate Interactions (Monitor Closely): - Warfarin: possible increase in INR; monitor coagulation. - Methotrexate: reduced renal clearance may raise serum levels. - Digoxin: slight increase in serum concentration. - Iron supplements: decreased absorption; separate dosing by at least 2 hours.